Technical Analysis for KIN - Kindred Biosciences, Inc.

Grade Last Price % Change Price Change
grade F 4.7 -1.47% -0.07
KIN closed down 1.47 percent on Friday, June 5, 2020, on 1.42 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat
Historical KIN trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
20 DMA Support Bullish -1.47%
NR7 Range Contraction -1.47%
MACD Bullish Signal Line Cross Bullish -4.67%
Up 3 Days in a Row Strength -4.67%
Shooting Star Candlestick Bearish -2.29%
Crossed Above 20 DMA Bullish -2.29%
Doji - Bearish? Reversal -2.29%
20 DMA Resistance Bearish -0.84%
Crossed Above 50 DMA Bullish -0.84%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Kindred Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development of therapies for pets. The company is pursuing small molecules and biologics that are in various stages of development for a range of indications in dogs, cats, and horses. Its products include CereKin, an oral interleukin-1 beta inhibitor for osteoarthritis pain and inflammation in dogs; AtoKin, a beef-flavored formulation of fexofenadine for atopic dermatitis in dogs; SentiKin, an oral analgesic formulation of flupirtine to manage post-operative pain in dogs and horses; KIND-007, an inhibitor of Bruton's tyrosine kinase; and KIND-006, an agent for gastrointestinal diseases in cats. The company also has a portfolio of other drugs and biologics under development, which comprise anti-IgE antibody for allergic and immune-mediated diseases; canine analog of Enbrel for inflammatory and autoimmune diseases; canine analog of Orencia for immune-mediated diseases; and KIND-504, a cancer vaccine. Kindred Biosciences, Inc. was founded in 2012 and is headquartered in Burlingame, California.
Medicine Biotechnology Biopharmaceutical Health Cancer Pain Immunology Immune System Inflammation Osteoarthritis Atopic Dermatitis Gastrointestinal Diseases Atopy Immune Mediated Diseases Inflammatory And Autoimmune Diseases Etanercept Flupirtine Immunoglobulin E

Is KIN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.93
52 Week Low 3.105
Average Volume 347,289
200-Day Moving Average 7.19
50-Day Moving Average 4.44
20-Day Moving Average 4.76
10-Day Moving Average 4.71
Average True Range 0.47
ADX 12.54
+DI 21.54
-DI 18.17
Chandelier Exit (Long, 3 ATRs ) 3.96
Chandelier Exit (Short, 3 ATRs ) 5.62
Upper Bollinger Band 5.26
Lower Bollinger Band 4.26
Percent B (%b) 0.44
BandWidth 21.07
MACD Line 0.00
MACD Signal Line -0.02
MACD Histogram 0.0134
Fundamentals Value
Market Cap 130.83 Million
Num Shares 27.8 Million
EPS -1.17
Price-to-Earnings (P/E) Ratio -4.02
Price-to-Sales 0.00
Price-to-Book 2.41
PEG Ratio -0.15
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.20
Resistance 3 (R3) 5.24 5.13 5.11
Resistance 2 (R2) 5.13 5.00 5.10 5.08
Resistance 1 (R1) 4.91 4.92 4.86 4.87 5.06
Pivot Point 4.80 4.80 4.77 4.77 4.80
Support 1 (S1) 4.58 4.67 4.53 4.54 4.34
Support 2 (S2) 4.47 4.59 4.44 4.32
Support 3 (S3) 4.25 4.47 4.29
Support 4 (S4) 4.21